BioXcel Therapeutics Announces Pricing of $7.0 Million

23 hours ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing …

CouponFollow Extension

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million

6 days from now

23 hours ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing …

globenewswire.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

23 hours ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing …

yahoo.com

$7
OFF

2024-11-22 | BioXcel Therapeutics Announces Pricing Of $7.0 …

6 days from now

1 day ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company&CloseCurlyDoubleQuote;) (Nasdaq: BTAI), a biopharmaceutical company …

stockhouse.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

23 hours ago · BioXcel Therapeutics announces pricing of public offering at $0.48 per share, grossing $7 million. ... Nov. 22, 2024 8:48 AM ET BioXcel Therapeutics, Inc. (BTAI) Stock By: …

seekingalpha.com

$7
OFF

BioXcel Therapeutics (BTAI) Announces Pricing Of $7.0 Million …

6 days from now

23 hours ago · BioXcel Therapeutics (BTAI) Announces Pricing of $7.0 Million Public Offering ... E-mail Address. StreetInsider.com Top Tickers, 11/22/2024. 1. ESTC 2. INTU 3. GAP 4. …

streetinsider.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public Of

6 days from now

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the â Companyâ ) ( BTAI), a biopharmaceutical company utilizing artificial i 🚀 Enjoy a 7-Day Free …

gurufocus.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence …

bioxceltherapeutics.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript; BioXcel announces common stock and warrants offering, no amount given; BioXcel Therapeutics GAAP EPS of -$0.32 …

msn.com

$0.00
OFF

BioXcel Therapeutics Prices 5.6M Shares At 48c In Public Offering

6 days from now

1 day ago · BioXcel Therapeutics (BTAI) announced the pricing of an underwritten public offering of 5,600,000 shares of its common stock, par value $0.001 per share and accompanying …

businessinsider.com

4%
OFF

Baystreet.ca - BioXcel Prices New Offering

6 days from now

22 hours ago · Each of the accompanying warrants will have an exercise price of $0.48 per underlying share of Common Stock. BTAI shares subsided 6.5 cents, or 11.4%, to 51 cents.

baystreet.ca

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

23 hours ago · BioXcel Therapeutics Announces Pricing of $7.0 Million Public Offering ... E-mail Address. StreetInsider.com Top Tickers, 11/22/2024. 1. ESTC 2. INTU 3. GAP 4. PCOR 5. ...

streetinsider.com

$7000000
OFF

Post-IPO Equity - BioXcel Therapeutics - 2024-11-21 - Crunchbase

6 days from now

BioXcel Therapeutics raised $7000000 on 2024-11-21 in Post-IPO Equity. Search Crunchbase. Start Free Trial . Chrome Extension. ... Summary. Overview. Edit Overview Section. …

crunchbase.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

23 hours ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the "Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing …

manilatimes.net

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the "Company") (NASDAQ:BTAI), a biopharmaceutical company utilizing artificial intelligence …

quantisnow.com

70%
OFF

BioXcel Therapeutics (BTAI) Stock Price, News & Analysis

6 days from now

3 days ago · 28.70% of the stock of BioXcel Therapeutics is held by insiders. A high percentage of insider ownership can be a sign of company health. ... BioXcel Therapeutics Reports Q3 2024 …

marketbeat.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public

6 days from now

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical...

advfn.com

$7
OFF

BioXcel Therapeutics Aktie: Unveränderte Prognosen Erwartet

6 days from now

2 hours ago · Die BioXcel Therapeutics Aktie verzeichnete am 23. ... 23.11.2024 Börsentäglich über 12.000 News von 677 internationalen ... BioXcel Therapeutics Announces Pricing of $7.0 …

finanznachrichten.de

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million ... - BioSpace

6 days from now

1 day ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial …

biospace.com

FAQs about BioXcel Therapeutics Announces Pricing of $7.0 Million Coupon?

What happened to bioxcel Therapeutics?

BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company. In its most recent financial year result, announced on 31 December 2022, the company reported a loss of US$166m. BioXcel Therapeutics utilizes artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology and has a market capitalization of US$579m. ...

What was the closing price of bioxcel Therapeutics Inc registered SHS?

On Thursday 08/22/2024 the closing price of the BioXcel Therapeutics Inc Registered Shs share was $0.65 on BTT. Compared to the opening price on Thursday 08/22/2024 on BTT of $0.67, this is a drop of 2.47%. BioXcel Therapeutics Inc Registered Shs's market capitalization is $27.14 M by 40.74 M shares outstanding. ...

How much did bioxcel Therapeutics raise in an IPO?

BioXcel Therapeutics (BTAI) raised $60 million in their IPO on Thursday, March 8th 2018. The company issued 5,000,000 shares at a price of $11.00-$13.00 per share. $60 million was raised in the IPO. ...

Is BioXcel Therapeutics profitable?

BioXcel Therapeutics is likely to remain unprofitable despite Igalmi generating more revenue due to increased expenses related to its launch and clinical programs. ...

What is the debt level of BioXcel Therapeutics?

A higher level of debt in BioXcel Therapeutics' case amounts to 73% of its equity. Generally, the rule of thumb is debt shouldn’t exceed 40% of your equity, which increases the risk around investing in a loss-making company. ...

Is bioxcel Therapeutics a good stock to buy?

According to analysts, BioXcel Therapeutics has a consensus rating of Hold. The company's average rating score is 2.43, based on 3 buy ratings, 4 hold ratings, and no sell ratings. BioXcel Therapeutics has only been the subject of 3 research reports in the past 90 days. ...